Get the Stockscreener App
0.3921
3.46%
0.0131
After Hours:
.40
0.0079
+2.01%
Co Diagnostics Inc stock is traded at $0.3921, with a volume of 5.78M.
It is up +3.46% in the last 24 hours and up +2.14% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$0.379
Open:
$0.3935
24h Volume:
5.78M
Relative Volume:
0.24
Market Cap:
$15.11M
Revenue:
$7.11M
Net Income/Loss:
$-41.28M
P/E Ratio:
-0.2841
EPS:
-1.38
Net Cash Flow:
$-26.84M
1W Performance:
-20.58%
1M Performance:
+2.14%
6M Performance:
+11.36%
1Y Performance:
-67.60%
1-Day Range:
$0.385
$0.44
1-Week Range:
$0.365
$0.5075
52-Week Range:
$0.2275
$1.55
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.3921 | 18.25M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
124.54 | 218.75B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.90 | 146.52B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
357.67 | 138.67B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.40 | 115.97B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.84 | 49.40B | 5.88B | 1.34B | 577.90M | 2.3455 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Co-Diagnostics explores strategic options for Indian joint venture By Investing.com - Investing.com South Africa
Co-Diagnostics explores strategic options for Indian joint venture - Investing.com
Co-Diagnostics engages Maxim Group to pursue SPAC transaction for its Indian joint venture, CoSara Diagnostics - MarketScreener
Co-Dx (NASDAQ: CODX) engages Maxim as exclusive financial advisor for CoSara JV SPAC - Stock Titan
Developing predictive dashboards with Co Diagnostics Inc. data2025 Market Overview & Low Risk Growth Stock Ideas - newser.com
Predicting Co Diagnostics Inc. trend using moving averages2025 Stock Rankings & Daily Market Momentum Tracking - newser.com
Is Co Diagnostics Inc. stock a top momentum playJuly 2025 Decliners & Low Risk High Reward Ideas - newser.com
Why Co Diagnostics Inc. stock could rally in 2025Weekly Investment Recap & Fast Moving Market Watchlists - newser.com
Will Co Diagnostics Inc. stock benefit from AI adoptionPortfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
How Co Diagnostics Inc. stock compares to industry benchmarksMarket Activity Summary & Real-Time Volume Analysis Alerts - newser.com
Is Co Diagnostics Inc. stock attractive after correctionInsider Selling & Reliable Breakout Stock Forecasts - newser.com
How sentiment analysis helps forecast Co Diagnostics Inc.Index Update & Safe Swing Trade Setup Alerts - newser.com
Chart overlay techniques for tracking Co Diagnostics Inc.Recession Risk & Precise Buy Zone Tips - newser.com
Will Co Diagnostics Inc. stock remain a Wall Street favoriteWeekly Trend Summary & AI Based Trade Execution Alerts - newser.com
What margin trends mean for Co Diagnostics Inc. stockJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Analyzing drawdowns of Co Diagnostics Inc. with statistical toolsJuly 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
AI Breakthrough in Biotech: Co-Diagnostics Unveils Primer AI, Revolutionizing Diagnostics and Disease Prediction - FinancialContent
Co-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx™ Primer Ai™ Platform - cnhinews.com
What recovery options are there for Co Diagnostics Inc.2025 Trade Ideas & AI Based Buy/Sell Signal Reports - newser.com
What’s next for Co Diagnostics Inc. stock priceJuly 2025 Trends & Weekly Setup with ROI Potential - newser.com
What technical models suggest about Co Diagnostics Inc.’s comebackJuly 2025 Decliners & Daily Entry Point Alerts - newser.com
Why Co Diagnostics Inc. stock remains on buy listsJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com
Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast - BioSpace
Is Co Diagnostics Inc. building a consolidation base2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
What is the fair value of Co Diagnostics Inc. stock nowInflation Watch & Weekly Stock Performance Updates - newser.com
Sentiment analysis tools applied to Co Diagnostics Inc.2025 Winners & Losers & Weekly Setup with High ROI Potential - newser.com
Co Diagnostics Inc. recovery potential after sell offMarket Rally & Entry Point Confirmation Alerts - newser.com
Co Diagnostics Inc Stock Analysis and ForecastHigh Dividend Yield Stocks & The Future of Wealth Is Just a Click Away - earlytimes.in
What drives Co Diagnostics Inc stock priceRisk Management Strategies & Swing Trade Smarter With Data Insights - earlytimes.in
CODX seeks reverse split authorization to address Nasdaq bid-price rule - Stock Titan
Co-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia - Your Wyoming Link
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.82%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):